Article information
Full text is only aviable in PDF
Bibliografía
[1.]
T.A. Waldman, R.B. Herberman.
Tumor markers in diagnosis and in monitoring therapy.
Cancer Medicine, pp. 1068-1089
[2.]
A. Malkin.
Tumor markers.
The basic Science of Oncology, pp. 192-203
[3.]
S.E. Bates, D.L. Longo.
Tumor markers: value and limitations in the management of cancer patients.
Cancer Treat Rev, 12 (1985), pp. 163-207
[4.]
J.P. Concannon, M.H. Dalbo, S.E. Hodgson, et al.
Prognostic value of preoperative carcinoembryonic antigen plasma levels with bronchogenic carcinoma.
Cancer, 42 (1978), pp. 1477-1487
[5.]
C.H.J. Ford, H.J. Stokes, C.E. Newman.
Carcinoembryonic antigen and prognosis after radical surgery for lung cancer.
Br J Cancer, 44 (1981), pp. 145-153
[6.]
T. Shinkai, N. Saijo, K. Tominaga, et al.
Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy.
Cancer, 57 (1986), pp. 1318-1323
[7.]
R.A. Stahel, G. Martz.
Prognostic and diagnostic usefulness of serum markers in lung cancer.
Eur J Cancer Clin Oncol, 23 (1987), pp. 893-894
[8.]
P. Santabárbara.
Fosfohexosa isomerasa y antígeno carcinoembrionario en el cáncer de pulmón.
Tesis Doctoral. Universidad de Barcelona, (1984),
[9.]
G. Bepler, G. Jaques, A. Koehler, et al.
Markers and characteristics of human SCLC cell lines.
J Cancer Res Clin Oncol, 113 (1987), pp. 253-259
[10.]
D.N. Carney, J.B. Mitchell, T.J. Kinsella.
In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variant.
Cancer Res, 43 (1983), pp. 2806-2811
[11.]
G. Bepler, D.N. Carney, M.M. Nau, et al.
Additive and differential biologic activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines.
Cancer Res, 46 (1986), pp. 3413-3419
[12.]
J.P. Sculier, R. Feld, W.K. Evans, et al.
Carcinoembryonic antig a useful prognostic marker in small-cell lung cancer.
J. Clin Oncol, 3 (1985), pp. 1349-1354
[13.]
P.B. Dent, P.B. McCulloch, O. Wesley-James, et al.
Measurements of carcinoembryonic antigen in patients with bronchogenic carcinoma.
Cancer, 42 (1978), pp. 1484-1491
[14.]
D.N. Carney, D.C. Ihde, M.H. Cohen, et al.
Serum neurospecific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
Lancet, 1 (1982), pp. 583-585
[15.]
D.H. Johnson, P.J. Marangos, J.T. Forbes, et al.
Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
Cancer Res, 44 (1984), pp. 5409-5414
[16.]
A. Navarro, E. Mur, J. Genollá, et al.
Neuron specific enolase serum levels in small cell lung cancer.
Proc ECCO, 4 (1987),
[17.]
H. Kato, T. Torigoe.
Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma.
Cancer, 56 (1985), pp. 302-308
[18.]
R. Molina, A.M. Ballesta, E. Letang, et al.
Tumor markers CA 12,5 and CA 19,9 in patients with lung cancer.
Tumor Biology, 6 (1985), pp. 394
[19.]
A.M. Ballesta, R. Molina, E. Casals, et al.
Value of CA 19 9 antigen as tumor marker: preliminary results.
Protides of the biological fluids. 32, pp. 627-630
[20.]
Molina R, Santabárbara P, Filella X, et al. CA 12,5 and CA 19,9 in primary lung cancer. Int J Biol Markers 1988 (en prensa).
[21.]
M. Barbacid.
Oncogenes humanos.
Avances en Oncología 1986, pp. 17-38
[22.]
E.A. Sausville, A.M. Lebacq-Verheyden, E.R. Spindel, et al.
Expression of the gastrin-releasing peptide gen in human small cell lung cancer.
J Biol Chem, 261 (1986), pp. 2451-2457
[23.]
F. cuttita, D.N. Carney, J. Mulshine, et al.
Bombesinlike peptides can function as autocrine growth factors in human small cell lung cancer.
Nature, 316 (1985), pp. 823-826
Copyright © 1988. Sociedad Española de Neumología y Cirugía Torácica
